Mandate

Vinge advises FCG in connection with the acquisition of Algorithmica Research

Vinge has advised Bridgepoint and FCG in connection with the acquisition of Algorithmica Research AB, a software technology provider of risk management and quantitative financial analytical solutions for the financial services industry.

Through the acquisition, FCG, leading Northern European experts in Governance, Risk & Compliance (“GRC”) with a strong track record of providing new and customer centered services to clients in the finance and insurance sector, adds new capabilities to enhance and further expand its technology area and product offerings.

Vinge’s team consisted primarily of partner Daniel Rosvall and associates Michaela Cronemyr, Fredric Reissmüller, Carl Fredrik Wachtmeister (M&A), Lisa Hörnqvist (Commercial Agreements), Lisa Ullman (Employment), Nathalie Hughes (VDR-assistant) also partner Alber Wållgren along with associates Josefin Lanker and Hannes Pettersson (Banking & Financing).

 

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026